logo-loader
NASDAQ:ABVC

ABVC Biopharma Inc

Receive alerts
Market:
NASDAQ
Price
0.91 USD
Day Change
-3.15%
Market Cap:
$24.56 m
52 weeks high
2.92
52 weeks low
0.71

In brief

ABVC BioPharma is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV1701/Vitargus) under development.

For its drug products, the company utilizes unlicensed technology from its network of world-renowned research institutions to conduct proof-of-concept trials through Phase II of clinical development. Its network of research institutions includes Stanford University, the University of California at San Francisco, and Cedars-Sinai Medical Center. For Vitargus, the company intends to conduct global clinical trials through Phase III.